The HI technique used in this study has been described in detail elsewhere (Gust, 1973) . Briefly, the test involved the treatment of sera with either kaolin or heparin-manganous chloride to remove nonspecific inhibitors, followed by adsorption with 50% pigeon erythrocytes. Doubling dilutions of the treated sera were incubated with 6 to 8 haemagglutinating doses of rubella antigen and 0-2 % pigeon erythrocytes.
The haemagglutination inhibition test (HI) is the most commonly used technique for the detection of antibodies to rubella virus. However, its satisfactory performance requires many manipulations of the test serum so that a reliable and more simple method for determining rubella antibody status would be a welcome addition to any laboratory now routinely performing this test. Recently, a passive haemagglutination test (PHA) for the detection of rubella antibodies has been developed (Rubacell, Abbott Laboratories, North Chicago, Illinois The HI technique used in this study has been described in detail elsewhere (Gust, 1973) . Briefly, the test involved the treatment of sera with either kaolin or heparin-manganous chloride to remove nonspecific inhibitors, followed by adsorption with 50% pigeon erythrocytes. Doubling dilutions of the treated sera were incubated with 6 to 8 haemagglutinating doses of rubella antigen and 0-2 % pigeon erythrocytes. Serum specimens were diluted 1:4 in phosphate buffered saline (PBS) and layered onto 10-40% (w/v) sucrose gradients in 5-0 ml polyallomer tubes. Sera to be tested by HI were first adsorbed with 50% pigeon erythrocytes to remove nonspecific agglutinins. Specimens were spun at 35 000 rpm for 18 hours using an SW 50-1 rotor in a Beckman L5-65 ultracentrifuge. Eight equal-volume fractions were collected from the bottom of the tubes and each was tested for the presence of antibodies by HI and/or PHA. Previous studies in this laboratory have shown that the majority of antibody in fractions 2 and 3 is IgM, and antibody detected in fractions 5 and 6 is invariably IgG (C. Birch-unpublished results).
2-MERCAPTOETHANOL TREATMENT OF SERA
Sera were pretreated with 25% kaolin and 50% pigeon erythrocytes (Gust, 1973) . Nine volumes of treated serum were incubated with one volume of 0 5 M 2-mercaptoethanol for one hour at 370C. As a control, PBS replaced the 0 5 M 2-mercaptoethanol.
Results

CONVENIENCE OF HI COMPARED WITH PHA
In the HI test, the removal of nonspecific inhibitors and agglutinins from test sera is a procedure requiring several manipulations and at least one fairly lengthy incubation period, so that in most laboratories the test is performed over two days. In contrast, the use of rubella-sensitised human erythrocytes in the PHA test alleviates treatment of serum and, depending on the number of sera to be tested, can be completed in less than 3 hours. In our hands, the HI test was considerably easier to read than the PHA, although, with practice, PHA end-points could be read with confidence.
HI ANTIBODY RESPONSE In each of the 11 patients with acute rubella, HI antibodies rose rapidly after the onset of the rash and reached maximum titre by day 10; 178 days postinfection these levels had decreased to approximately half the maximum level. At day 10 high levels of rubella-specific IgM were detectable in all sera, but at 57 days post-infection IgM antibody remained detectable in very low levels in only two of the children. The typical HI response of three children is shown in Figure 1 . (Dudgeon, 1967; Forrest and Menser, 1975) Although realising that the antigens used in the HI and PHA tests were probably not the same, it was thought that the delay in the development of PHA antibody may have been due to the presence of rubella-specific IgM in the serum which, in an unknown fashion, inhibited the PHA reaction. To test this hypothesis, sera negative by PHA but positive by HI and known to contain rubellaspecific IgG and IgM were treated with 2-mercaptoethanol or centrifuged through sucrose gradients to separate the IgG and IgM components. Antibody remained undetectable by PHA in the 2-mercaptoethanol-treated sera and in the IgG and IgM fractions of the serum, whereas antibodies were still detectable by HI in both cases, although at reduced levels in the 2-mercaptoethanol-treated sera. These results suggested that IgM was not involved in a nonspecific blocking reaction, and this was confirmed when two sera, obtained 57 days after the first appearance of the rash, were found to be positive for rubella-specific IgM and positive for total antibody by PHA. When the IgG and IgM fractions from the same two sera were treated with sensitised erythrocytes, only those fractions containing IgG agglutinated, suggesting that the PHA test is IgG specific.
The lack of reaction between sera negative by PHA but positive for IgG and IgM by HI with the rubella-sensitised erythrocytes and anti-human globulin demonstrated the lack of avidity between the antigen on the cells for antibody produced shortly after the appearance of the rash.
In view of the ease of performance of the PHA test and its comparable sensitivity to HI, PHA is a useful addition to the diagnostic laboratory for immune status determinations. The PHA test avoids the necessity for removal of nonspecific inhibitors and nonspecific agglutinins of pigeon erythrocytes from test sera, and does not require several incubation and centrifugation procedures necessary for the performance of the HI test. However, laboratories using the PHA kit routinely also need to be able to confirm negative PHA results using the HI test or, alternatively, require the facilities provided by a reference laboratory when the diagnosis of a recent rubella infection is in doubt.
